[Comparative study of the effectiveness of 9,33"-diacetylmidecamycin (MOM) and midecamycin on respiratory tract infection].
Authors | K Hara, K Izumikawa, M Komori, M Fukui, H Iwasaki, H Tomita, N Suyama, M Sai, A Saito, M Nakatomi, A Saito, M Tomizawa, I Nakayama, Y Kinoshita, S Kosaka, M Nakamura, S Arai, I Honda, I Hayashi, T Aoyagi, M Katsu, S Okui, M Adachi, K Nakagawa, M Koyama, H Tanimoto, K Nakada, A Tachibana, K Suzuki, H Kobayashi, M Takamura, I Fujimori, T Katayama, O Sekine, Y Usuda, N Aoki, T Cho, T Oyanagi, T Masuda, N Maekawa, M Nakanishi, M Kawai, T Kurasawa, H Nishiyama, K Bando, N Sakurai, S Muto, T Murayama, T Tsujimoto, S Hayashi |
Journal | Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
(Kansenshogaku Zasshi)
Vol. 56
Issue 11
Pg. 1045-91
(Nov 1982)
ISSN: 0387-5911 [Print] Japan |
PMID | 6819327
(Publication Type: Clinical Trial, Comparative Study, Journal Article)
|
Chemical References |
- Leucomycins
- Miocamycin
- midecamycin
|
Topics |
- Adult
- Aged
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Humans
- Leucomycins
(therapeutic use)
- Male
- Middle Aged
- Miocamycin
- Pneumonia
(drug therapy)
- Pneumonia, Mycoplasma
(drug therapy)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|